Literature DB >> 22632442

Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: a multicenter study in Japan.

Toshio Shimizu1, Utako Nagaoka, Yuki Nakayama, Akihiro Kawata, Chiharu Kugimoto, Yoshiyuki Kuroiwa, Mitsuru Kawai, Takayoshi Shimohata, Masatoyo Nishizawa, Ban Mihara, Hajime Arahata, Naoki Fujii, Reiko Namba, Hiroaki Ito, Takashi Imai, Keigo Nobukuni, Kiyohiko Kondo, Mieko Ogino, Takashi Nakajima, Tetsuo Komori.   

Abstract

Malnutrition in the early stage has been reported as an independent predictor of survival in amyotrophic lateral sclerosis (ALS). We analyzed retrospectively the effect of variation of body mass index (BMI) on survival in ALS patients. In total, 77 consecutive ALS patients were enrolled from nine hospitals in Japan. Reduction rate of BMI was calculated from BMI before the disease onset and at the time of the first visit to each hospital. We analyzed the correlation between BMI reduction rate and total disease duration. Results showed that the median BMI reduction rate was 2.5 per year (interquartile range 1.3-3.8). The BMI reduction rate was significantly correlated with survival length (p <0.0001). There was also a significant difference in survival between ALS patients with a BMI reduction rate ≥ and < 2.5 (Kaplan-Meier survival analysis and the log-rank test, p < 0.0001; hazard ratio by the Cox model, 2.9816). In conclusion, faster reduction of BMI at the initial stage before the first visit to hospital predicts shorter survival length also in Japanese ALS patients.

Entities:  

Mesh:

Year:  2012        PMID: 22632442     DOI: 10.3109/17482968.2012.678366

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  28 in total

1.  Under-recognized primary spontaneous pneumothorax in ALS: a multicenter retrospective study.

Authors:  Jin-Sung Park; Young Woo Do; Jin-Mo Park; Hung Youl Seok; Donghwi Park
Journal:  Neurol Sci       Date:  2019-07-02       Impact factor: 3.307

2.  Body Mass Index and Amyotrophic Lateral Sclerosis: A Study of US Military Veterans.

Authors:  Daniela Mariosa; John D Beard; David M Umbach; Rino Bellocco; Jean Keller; Tracy L Peters; Kelli D Allen; Weimin Ye; Dale P Sandler; Silke Schmidt; Fang Fang; Freya Kamel
Journal:  Am J Epidemiol       Date:  2017-03-01       Impact factor: 4.897

3.  Maximum Tongue Pressure is Associated with Swallowing Dysfunction in ALS Patients.

Authors:  Aya Hiraoka; Mineka Yoshikawa; Masahiro Nakamori; Naohisa Hosomi; Toshikazu Nagasaki; Takahiro Mori; Masaya Oda; Hirofumi Maruyama; Mitsuyoshi Yoshida; Yuishin Izumi; Masayasu Matsumoto; Kazuhiro Tsuga
Journal:  Dysphagia       Date:  2017-04-19       Impact factor: 3.438

Review 4.  Symptom Management and End-of-Life Care in Amyotrophic Lateral Sclerosis.

Authors:  Carlayne E Jackson; April L McVey; Stacy Rudnicki; Mazen M Dimachkie; Richard J Barohn
Journal:  Neurol Clin       Date:  2015-11       Impact factor: 3.806

5.  An exploratory study of serum creatinine levels in patients with amyotrophic lateral sclerosis.

Authors:  Xueping Chen; Xiaoyan Guo; Rui Huang; Zhenzhen Zheng; Yongping Chen; Hui-Fang Shang
Journal:  Neurol Sci       Date:  2014-04-30       Impact factor: 3.307

6.  Safety and Clinical Benefits of Laryngeal Closure in Patients with Amyotrophic Lateral Sclerosis.

Authors:  Sayaka Yokoi; Naoki Nishio; Takashi Maruo; Mariko Hiramatsu; Nobuaki Mukoyama; Hidenori Tsuzuki; Akihisa Wada; Naoki Atsuta; Daisuke Ito; Takashi Tsuboi; Gen Sobue; Masahisa Katsuno; Yasushi Fujimoto; Michihiko Sone
Journal:  Dysphagia       Date:  2022-05-04       Impact factor: 3.438

7.  Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia.

Authors:  Raphael Simon Peter; Angela Rosenbohm; Luc Dupuis; Torben Brehme; Jan Kassubek; Dietrich Rothenbacher; Gabriele Nagel; Albert Christian Ludolph
Journal:  Eur J Epidemiol       Date:  2017-10-03       Impact factor: 8.082

8.  Prognostic significance of body weight variation after diagnosis in ALS: a single-centre prospective cohort study.

Authors:  Toshio Shimizu; Yuki Nakayama; Chiharu Matsuda; Michiko Haraguchi; Kota Bokuda; Kazuko Ishikawa-Takata; Akihiro Kawata; Eiji Isozaki
Journal:  J Neurol       Date:  2019-03-13       Impact factor: 4.849

Review 9.  Body mass index and survival from amyotrophic lateral sclerosis: A meta-analysis.

Authors:  Efthimios Dardiotis; Vasileios Siokas; Maria Sokratous; Zisis Tsouris; Athina-Maria Aloizou; Desponia Florou; Metaxia Dastamani; Alexios-Fotios A Mentis; Alexandros G Brotis
Journal:  Neurol Clin Pract       Date:  2018-10

10.  Behavioral, Hormonal, Inflammatory, and Metabolic Effects Associated with FGF21-Pathway Activation in an ALS Mouse Model.

Authors:  J B Delaye; D Lanznaster; C Veyrat-Durebex; A Fontaine; G Bacle; A Lefevre; R Hergesheimer; J C Lecron; P Vourc'h; C R Andres; F Maillot; P Corcia; P Emond; H Blasco
Journal:  Neurotherapeutics       Date:  2020-10-06       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.